Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
$39.12-3.50%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $5.15B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,946,023
- 52-week high
- —
- 52-week low
- —
- Open
- $40.54
- Day high
- $40.98
- Day low
- $39.01
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $1.24B | $210M | $1.64 |
| 2024 | $1.19B | $61M | $0.05 |
| 2023 | $1.09B | -$126M | -$0.92 |
| 2022 | $901M | -$44M | -$0.32 |
About Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
- CEO
- Joseph J. Ciaffoni
- Employees
- 1,030
- Country
- US
- IPO date
- Dec 29, 2014
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Indivior Pharmaceuticals, Inc.'s stock price today?
- INDV is trading at $39.12 as of Jul 20, 2026.
- What is Indivior Pharmaceuticals, Inc.'s market cap?
- Indivior Pharmaceuticals, Inc. (INDV) has a market capitalization of $5.15B.
- Does Indivior Pharmaceuticals, Inc. pay a dividend?
- Indivior Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Indivior Pharmaceuticals, Inc. in?
- Indivior Pharmaceuticals, Inc. operates in the Healthcare sector.